secwatch / observer
8-K filed May 30, 2023, 7:59 PM ET ticker FNCHQ CIK 0001733257
other material confidence high sentiment neutral materiality 0.35

Finch Therapeutics enters consulting agreement with former CEO Mark Smith; up to $150K performance pay

Finch Therapeutics Group, Inc.

Finch Therapeutics Group, Inc. filing history →

Source: SEC EDGAR
accession 0001193125-23-156571
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.